Jason Throne - 01 Mar 2022 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
SVP, General Counsel
Signature
/s/ Jason Throne
Issuer symbol
IDYA
Transactions as of
01 Mar 2022
Transactions value $
$0
Form type
4
Date filed
02 Mar 2022, 18:40
Previous filing
29 Jul 2021
Next filing
28 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (Right to Buy) Award $0 -63.8K -50% $0.00 63.8K 01 Mar 2022 Common Stock 63.8K $12.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.